Effects of Lithium on Magnetic Resonance Imaging Signal Might Not Preclude Increases in Brain Volume After Chronic Lithium Treatment

Published:September 03, 2013DOI:
      We read with great interest the thoughtful recent article in which Cousins et al. (
      • Cousins D.A.
      • Aribisala B.
      • Ferrier I.N.
      • Blamire A.M.
      Lithium, gray matter, and magnetic resonance imaging signal.
      ) suggested that the structural brain changes associated with lithium (Li) treatment might not be physical increases in brain volume but rather an artifact caused by shortening of the gray matter (GM) T1 relaxation times by Li. We agree that interpretation of clinical neuroimaging studies investigating the effects of Li on brain structure is unclear, particularly as to the factors underlying potential GM changes. However, although Li treatment might alter contrast in T1 weighted magnetic resonance (MR) images, we here advance clinical and preclinical evidence why this might not preclude a tangible change in brain volume.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cousins D.A.
        • Aribisala B.
        • Ferrier I.N.
        • Blamire A.M.
        Lithium, gray matter, and magnetic resonance imaging signal.
        Biol Psychiatry. 2013; 73: 652-657
        • Hajek T.
        • Cullis J.
        • Novak T.
        • Kopecek M.
        • Hoschl C.
        • Blagdon R.
        • et al.
        Hippocampal volumes in bipolar disorders: Opposing effects of illness burden and lithium treatment.
        Bipolar Disord. 2012; 14: 261-270
        • Yucel K.
        • Taylor V.H.
        • McKinnon M.C.
        • Macdonald K.
        • Alda M.
        • Young L.T.
        • et al.
        Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment.
        Neuropsychopharmacology. 2008; 33: 361-367
        • Hwang J.
        • Lyoo I.K.
        • Dager S.R.
        • Friedman S.D.
        • Oh J.S.
        • Lee J.Y.
        • et al.
        Basal ganglia shape alterations in bipolar disorder.
        Am J Psychiatry. 2006; 163: 276-285
        • Hajek T.
        • Kopecek M.
        • Hoschl C.
        • Alda M.
        Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: A meta-analysis.
        J Psychiatry Neurosci. 2012; 37: 110-143
        • Hallahan B.
        • Newell J.
        • Soares J.C.
        • Brambilla P.
        • Strakowski S.M.
        • Fleck D.E.
        • et al.
        Structural magnetic resonance imaging in bipolar disorder: An international collaborative mega-analysis of individual adult patient data.
        Biol Psychiatry. 2011; 69: 326-335
        • Yucel K.
        • McKinnon M.C.
        • Taylor V.H.
        • Macdonald K.
        • Alda M.
        • Young L.T.
        • et al.
        Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: A longitudinal MRI study.
        Psychopharmacology (Berl). 2007; 195: 357-367
        • Hajek T.
        • Bauer M.
        • Pfennig A.
        • Cullis J.
        • Ploch J.
        • O’donovan C.
        • et al.
        Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study.
        J Psychiatry Neurosci. 2012; 37: 185-192
        • Silverstone P.H.
        • Wu R.H.
        • O’Donnell T.
        • Ulrich M.
        • Asghar S.J.
        • Hanstock C.C.
        Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients.
        Int Clin Psychopharmacol. 2003; 18: 73-79
        • Walterfang M.
        • Wood A.G.
        • Barton S.
        • Velakoulis D.
        • Chen J.
        • Reutens D.C.
        • et al.
        Corpus callosum size and shape alterations in individuals with bipolar disorder and their first-degree relatives.
        Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33: 1050-1057
        • Monkul E.S.
        • Matsuo K.
        • Nicoletti M.A.
        • Dierschke N.
        • Hatch J.P.
        • Dalwani M.
        • et al.
        Prefrontal gray matter increases in healthy individuals after lithium treatment: A voxel-based morphometry study.
        Neurosci Lett. 2007; 429: 7-11
        • Vernon A.C.
        • Natesan S.
        • Crum W.R.
        • Cooper J.D.
        • Modo M.
        • Williams S.C.
        • et al.
        Contrasting effects of haloperidol and lithium on rodent brain structure: A magnetic resonance imaging study with postmortem confirmation.
        Biol Psychiatry. 2012; 71: 855-863
        • Licht R.W.
        • Larsen J.O.
        • Smith D.
        • Braendgaard H.
        Effect of chronic lithium treatment with or without haloperidol on number and sizes of neurons in rat neocortex.
        Psychopharmacology (Berl). 1994; 115: 371-374
        • Sawiak S.J.
        • Wood N.I.
        • Williams G.B.
        • Morton A.J.
        • Carpenter T.A.
        Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry.
        Neurobiol Dis. 2009; 33: 20-27
        • Lerch J.P.
        • Carroll J.B.
        • Dorr A.
        • Spring S.
        • Evans A.C.
        • Hayden M.R.
        • et al.
        Cortical thickness measured from MRI in the YAC128 mouse model of Huntington’s disease.
        Neuroimage. 2008; 41: 243-251

      Linked Article